Clinical Trial

The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE

Name: The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE — clinical trial record (NCT07185269)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This study will evaluate the effect and safety of 626 in patients with SLE

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-09-18.

Status change: Not Yet Recruiting → Recruiting 2025-11-25

Trial Details

NCT Number	NCT07185269
Lead Sponsor	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions	Systemic Lupus Erythematosus (SLE)
Enrollment	198 participants
Start Date	2025-09-24
Primary Completion	2028-08-12 (estimated)
Study Completion	2028-11-04 (estimated)
Updated on ClinicalTrials.gov	2025-11-26